Back to Search Start Over

Mendelian Susceptibility to Mycobacterial Disease Caused by a Novel Founder IL12B Mutation in Saudi Arabia.

Authors :
Alodayani AN
Al-Otaibi AM
Deswarte C
Frayha HH
Bouaziz M
AlHelale M
Le Voyer T
Nieto-Patlan A
Rattina V
AlZahrani M
Halwani R
Al Sohime F
Al-Mousa H
Al-Muhsen S
Alhajjar SH
Dhayhi NS
Abel L
Casanova JL
Bin-Hussain I
AlBarrak MS
Al-Jumaah SA
Bustamante J
Source :
Journal of clinical immunology [J Clin Immunol] 2018 Apr; Vol. 38 (3), pp. 278-282. Date of Electronic Publication: 2018 Mar 27.
Publication Year :
2018

Abstract

Purpose: Mendelian susceptibility to mycobacterial disease (MSMD) is a rare primary immunodeficiency predisposing congenitally affected individuals to diseases caused by weakly virulent mycobacteria, such as Bacillus Calmette-Guérin (BCG) vaccine strains and environmental mycobacteria. IL-12p40 deficiency is a genetic etiology of MSMD resulting in impaired IL-12- and IL-23-dependent IFN-γ immunity. Most of the reported patients with IL-12p40 deficiency originate from Saudi Arabia (30 of 52) and carry the recurrent IL12B mutation c.315insA (27 of 30).<br />Methods: Whole-exome sequencing was performed on three patients from two unrelated kindreds from Saudi Arabia with disseminated disease caused by a BCG vaccine substrain.<br />Results: Genetic analysis revealed a homozygous mutation, p.W60X, in exon 3 of the IL12B gene, resulting in complete IL12p40 deficiency. This mutation is recurrent due to a new founder effect.<br />Conclusions: This report provides evidence for a second founder effect for recurrent mutations of IL12B in Saudi Arabia.

Details

Language :
English
ISSN :
1573-2592
Volume :
38
Issue :
3
Database :
MEDLINE
Journal :
Journal of clinical immunology
Publication Type :
Academic Journal
Accession number :
29589181
Full Text :
https://doi.org/10.1007/s10875-018-0490-2